{
    "clinical_study": {
        "@rank": "166666", 
        "arm_group": {
            "arm_group_label": "Standard IVF/ICSI treatment"
        }, 
        "biospec_descr": {
            "textblock": "Serum, Embryo culture media"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The aim of this study is to achieve a more profound understanding of the endocrine\n      alteration in luteal progesterone level after gonadotrophin stimulated IVF/ICSI cycles and\n      to explore the optimal  progesterone level needed for securing implantation and development\n      of early pregnancy.\n\n      The second part of the project will determine the value of Preimplantation Factor (PIF)\n      measurement in embryo culture medium as a possible tool for improved embryo selection and\n      the use of PIF as an early pregnancy serum marker for healthy implantation and embryo\n      development.\n\n      IVF: In vitro fertilisation, ICSI: Intracytoplasmic sperm injection."
        }, 
        "brief_title": "The Role of Progesterone and PIF for Successful Implantation and On-going Pregnancy in Assisted Reproductive Technology", 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        -All women undergoing IVF/ICSI treatment at the participating clinics in either antagonist\n        protocol or long agonist protocol will be offered participation.\n\n        Exclusion Criteria:\n\n        -Prior participation in the study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients undergoing IVF/ICSI treatment at 4 Danish Fertility Centres."
            }
        }, 
        "enrollment": {
            "#text": "900", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02129998", 
            "org_study_id": "Progesterone/PIF_Skive"
        }, 
        "intervention": {
            "arm_group_label": "Standard IVF/ICSI treatment", 
            "intervention_name": "IVF/ICSI treatment", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Progesterone"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Infertility", 
            "IVF/ICSI", 
            "Progesterone", 
            "Preimplantation Factor (PIF)"
        ], 
        "lastchanged_date": "May 1, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Skive", 
                    "country": "Denmark", 
                    "zip": "7800"
                }, 
                "name": "The Fertility Clinic Skive"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Role of Luteal Progesterone and Preimplantation Factor (PIF) for Successful Implantation and On-going Pregnancy in Assisted Reproductive Technology", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Denmark: The Danish National Committee on Biomedical Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "On-going pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "10th week of gestation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02129998"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Regionshospitalet Viborg, Skive", 
            "investigator_full_name": "Peter Humaidan", 
            "investigator_title": "Professor, DMSc", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Implantation rate", 
            "safety_issue": "No", 
            "time_frame": "7th week of gestation"
        }, 
        "source": "Regionshospitalet Viborg, Skive", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Ferring Pharmaceuticals", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "BioIncept LLC", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Regionshospitalet Viborg, Skive", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}